Investigation of the Toxic Functional Group of Cephalosporins by Zebrafish Embryo Toxicity Test
Authors:
- 11 October 2010
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 343 (10) , 553-560
Abstract
2‐mercapto‐5‐methyl‐1,3,4‐thiadiazole (MMTD) is the 3'‐side chain of cephalosporin including cefazolin sodium (CFZL) and cefazedone (CFZD). It is not only present in finished products as the residual precursor, but also produced through drug degradation. Performing the zebrafish embryo toxicity test, we evaluated the toxicity effects of cefazolin sodium, cefazedone, their synthetic precursors and intermediates. Our results suggest that the teratogenic effect of cefazedone and cefazolin sodium on zebrafish embryonic development is associated with the structure of MMTD. They mainly interfere with the development of tissues and organs derived from embryonic ectoderm and mesoderm. We further consider the rationality of the quality control limit of MMTD (1.0%) in the specification. As the acceptable daily intakes (ADIs) of cefazolin is 10 µg/kg per day 16 and the minimum teratogenic concentration of MMTD is tenfold lower than that of cefazolin sodium, we recommend that the acceptable daily intakes of MMTD should be 1 µg/(kg day). In general, the therapeutic dose of cefazolin sodium is 2–4 g/day. Based upon the calculation of MMTD quality control limits (1.0%), MMTD intake can be 20–40 mg/day, which will be much more than the acceptable daily intake value of 1 µg/(kg day). Thus, MMTD should be recommended as a specified impurity and qualified as serious again.Keywords
This publication has 15 references indexed in Scilit:
- Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discoveryBritish Journal of Pharmacology, 2008
- Computational modeling of biologically active molecules using NMR spectraDrug Discovery Today, 2006
- Zebrafish assays for drug toxicity screeningExpert Opinion on Drug Metabolism & Toxicology, 2006
- β-Lactams in the New Millennium. Part-II: Cephems, Oxacephems, Penams and SulbactamMini-Reviews in Medicinal Chemistry, 2004
- Biological Activity of Some Monocyclic- and Bicyclic β-Lactams with Specified Functional GroupsMini-Reviews in Medicinal Chemistry, 2003
- Energetic, structural, and antimicrobial analyses of β-lactam side chain recognition by β-lactamasesChemistry & Biology, 2001
- Studies on orally active cephalosporins. I. Synthesis and structure-activity relationships of new 3-substituted carbamoyloxymethyl cephalosporins.The Journal of Antibiotics, 1994
- Synthesis and oral activity of ME 1207, a new orally active cephalosporin.The Journal of Antibiotics, 1990
- Studies on orally active cephalosporin esters.The Journal of Antibiotics, 1987
- Studles on β-Lactam Antibiotics for Medicinal Purpose. XVIIIYAKUGAKU ZASSHI, 1986